regulatory
confidence high
sentiment positive
materiality 0.60
BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable
BECTON DICKINSON & CO
- BD voluntarily placed ChloraPrep and PurPrep on ship hold on May 6, 2026 for additional final release testing.
- Shipments of ChloraPrep have resumed in the U.S. after completion of additional assessments and testing.
- All additional final release testing performed to date has been acceptable; no patient safety signals.
- The ship hold was in response to the FDA Warning Letter for the El Paso manufacturing facility.
- Detailed risks associated with the Warning Letter are described in BD's Q1 FY2026 10-Q filing.